No Data
Chiome Bioscience Revises Forecast Amid Financial Challenges
Chiome Bioscience: Financial results supplementary materials 3rd quarter of the fiscal year ending 2024/12
Chiome Bioscience: Notice regarding the recording of non-operating expenses and revisions to earnings forecasts
Chiome Bioscience: Summary of financial results for the 3rd quarter of the fiscal year ending 2024/12 [Japanese GAAP] (unconsolidated)
Chiome Bioscience 9-Mos Parent Loss Y915.00M Vs Loss Y918.00M
Daiwa House, Idemitsu Kosan, Tokyo Electron Ltd. unsponsored adr, SoftBank Group (12th)
※Please note that the above calendar is subject to change depending on the company's circumstances. --------------------------------------- November 12 (Tuesday) ＜1431＞ Livework ＜146A＞ Colombia ＜148A＞ Hatchwork ＜1491＞ Chugai Mining ＜1605＞ INPEX ＜1663＞ K&O Energy ＜166A＞ Taski HD ＜1770＞ Fujita E
No Data
No Data